These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Systemic therapy of psoriasis]. Altmeyer P; Nüchel C Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1605-7. PubMed ID: 9011488 [No Abstract] [Full Text] [Related]
3. Psoriasis treatment: traditional therapy. Lebwohl M; Ting PT; Koo JY Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii83-6. PubMed ID: 15708945 [TBL] [Abstract][Full Text] [Related]
4. Drug delivery and formulations for the topical treatment of psoriasis. Su YH; Fang JY Expert Opin Drug Deliv; 2008 Feb; 5(2):235-49. PubMed ID: 18248321 [TBL] [Abstract][Full Text] [Related]
5. Treatment of psoriasis. Part 2. Systemic therapies. Lebwohl M; Ali S J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913 [TBL] [Abstract][Full Text] [Related]
6. [Role of new biological therapy in psoriasis treatment]. Cortijo Cascajares S; García Rodríguez MP; Campo Angora M; Serrano Garrote O; Herreros de Tejada A Farm Hosp; 2004; 28(3):192-200. PubMed ID: 15222873 [TBL] [Abstract][Full Text] [Related]
7. Treatment policy for psoriasis and eczema: a survey among dermatologists in the Netherlands and Belgian Flanders. Roelofzen JH; Aben KK; Khawar AJ; Van de Kerkhof PC; Kiemeney LA; Van Der Valk PG Eur J Dermatol; 2007; 17(5):416-21. PubMed ID: 17673386 [TBL] [Abstract][Full Text] [Related]
8. Tacrolimus ointment 0.1% alone and in combination with medium-dose UVA1 in the treatment of palmar or plantar psoriasis. Rivard J; Janiga J; Lim HW J Drugs Dermatol; 2006 Jun; 5(6):505-10. PubMed ID: 16774101 [TBL] [Abstract][Full Text] [Related]
9. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists. Katz HI J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188 [TBL] [Abstract][Full Text] [Related]
10. Novel pharmacological approaches in the treatment of psoriasis. Schleyer V; Landthaler M; Szeimies RM J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):1-20. PubMed ID: 15649186 [TBL] [Abstract][Full Text] [Related]
11. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan. Feldman SR; Evans C; Russell MW J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166 [TBL] [Abstract][Full Text] [Related]
13. Psoriasis of the face and flexures. van de Kerkhof PC; Murphy GM; Austad J; Ljungberg A; Cambazard F; Duvold LB J Dermatolog Treat; 2007; 18(6):351-60. PubMed ID: 17907013 [TBL] [Abstract][Full Text] [Related]
14. [Psoriasis--clinical picture and current therapy]. Shakery K; Reich K Med Monatsschr Pharm; 2009 Sep; 32(9):335-44; quiz 345-6. PubMed ID: 19795696 [TBL] [Abstract][Full Text] [Related]
15. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Naldi L; Griffiths CE Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088 [TBL] [Abstract][Full Text] [Related]
17. [The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis']. Spuls PI; Tuut MK; van Everdingen JJ; de Rie MA; Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2121-5. PubMed ID: 15553355 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of 308nm laser treatment of psoriasis compared to historical controls. Rodewald EJ; Housman TS; Mellen BG; Feldman SR Dermatol Online J; 2001 Dec; 7(2):4. PubMed ID: 12165220 [TBL] [Abstract][Full Text] [Related]
19. [Immunosuppresive agents, retinoids and new trends in the therapy of psoriasis]. Svozil M Ceska Slov Farm; 2002 Nov; 51(6):267-72. PubMed ID: 12501485 [TBL] [Abstract][Full Text] [Related]
20. Psoriasis: hope for the future. Sullivan-Whalen M; Gilleaudeau P Nurs Clin North Am; 2007 Sep; 42(3):467-84, vii. PubMed ID: 17825665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]